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Abstract 
Sphingomyelin-based liposomes were prepared and applied on the stratum corneum 
side or basal layer side of three-dimensional cultured human skin model, and the increase in 
type II ceramide (ceramide II) level was evaluated in the cultured skin model.  The 
sphingomyelin-based liposomes were prepared by a high pressure emulsification method and 
the obtained liposomes were characterized; particle diameter and zeta potential of the 
liposomes were 155.3 nm and -11.4 mV, respectively.  Spherical shape and lamella structure 
were observed by transmission electron microscopy.  The sphingomyelin-based liposomes or 
saline were applied on the cultured skin model, and ceramide II was extracted from the skin 
model.  The extracted ceramide II was separated by an HPTLC and quantified by a 
densitometer.    The amount of ceramide II in the cultured skin model was significantly 
increased by application of the sphingomyelin-based liposomes compared with the 
non-application group.  Thus, the sphingomyelin-based liposomes are useful to enrich the 
ceramide level in the three dimensional cultured skin model. 
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1. Introduction 
Transdermal drug delivery offers many potential advantages over conventional 
methods for drug delivery (Schreier, 1994, Cevc, 1996, Touitou, 2000, Barry, 2001).  Skin has 
been used as an application site of therapeutic drugs to avoid the hepatic first pass effect and 
side effects in the GI tract.  Thus, topical formulations applied on skin are beneficial, 
especially for infants and elder patients who sometimes have difficulty for swallowing 
medicines.  Recently, several functional cosmetics were developed and used.  These articles 
are very similar to topical drug formulations like creams, ointments, gels, lotions and etc.  
Some of active cosmetic ingredients must penetrate skin to have effective function for 
cosmetics. 
However, the uppermost layer of the skin, the stratum corneum (SC), having 10-40 
µm-thick except for the palm of hands and feet bottoms, and composing of partly flattened 
and keratinized layers, acts as an excellent intrinsic barrier for preventing water transpiration 
from inside of the body and against invasion of several chemicals and drugs (Abraham, 1990, 
Elias, 1975, Holleran, 1991).  Thus, the SC plays an important role as a penetration barrier 
against most therapeutic drugs.  SC has the special structure having keratinocytes as blicks 
and interceller lipids filled up as mortar structure (Elias, 1983, Uchida, 1988).  Intercellular 
lipids of the SC were composed by sphingolipids like ceramides, cholesterols, cholesterol 
esters and fatty acids (Swartzendruber, 1989, Bowstra, 1995).  Particularly, ceramides which 
are half of the intercellular lipids, have the most important roles for the barrier function in SC 
(Imokawa, 1985, Imokawa, 1991).  Disruption or lack of the SC lipids decreased the skin 
barrier function and skin-moisturising function.  They caused dry skin and sometimes 
several skin diseases.  It is also reported that sphingolipids like ceramides significantly 
decreased and inhibited the barrier function of skin especially in atopic dermatitis-patients 
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(Imokawa, 1991, Jensen, 2004; Farwanah, 2005).   
Major ceramides in the SC are derived from glucosylceramide and sphingomyelin 
(Fig. 1).  All species of ceramides are available through glucocerebrosidase activity, while 
only two species (type II and V ceramide) are generated through hydrolysis of sphingomyelin 
by sphingomyelinase (Motta, 1995, Jensen, 2004, Vicanova, 1998), as explained in Fig. 1.  
These ceramides are then metabolized to sphingosine and free fatty acids by ceramidase 
(Yada, 1995).  Thus, the amount of ceramides in SC is controlled by the three enzymes; 
glucocerebrosidase, sphingomyelinase and ceramidase. 
 
Figure 1 
 
Sphingomyelin is one of the phospholipids which are primary components of 
biomembrane.  It is hydrolyzed by sphingomyelinase in process of the differentiation from 
granular cells to corneocytes in the epidermis, and metabolized to ceramides and 
phosphocholine (Grayson, 1985) (Fig. 1).  Therefore, ceramide level in skin may be 
increased, if sphingomyelin is successfully delivered to the viable epidermis.  However, 
sphingomyelin is difficult to formulate in the topical formulations and cosmetics, since this 
phospholipid is not soluble and stable in the aqueous formulations which are frequently used 
for cosmetics. 
In this paper, sphingomyelin-based liposomes without entrapped drugs and active 
ingredients were prepared and utilized to enrich ceramides in skin, since liposomes are one of 
the useful formulations for phospholipids as well as entrapped novel drugs.  The latter is 
broadly used to deliver doxorubicin, amphotericin B, and so on in patients.  The presently 
prepared liposomes were characterized by their particle diameter, zeta potential and TEM 
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images.  Then, the sphingomyelin-based liposomes were applied to three-dimensional 
cultured human skin model to evaluate whether they can increase ceramide level in the 
cultured skin. 
 
2. Materials and Methods 
2-1. Materials 
Sphingomyelin from milk was purchased by NOF Corporation (Tokyo, Japan).  
Ceramide II standard was obtained Nikko Chemical Co., Ltd. (Tokyo, Japan).  
[N-methyl-
14
C] Sphingomyelin was purchased by GE Healthcare UK Ltd. (Buckinghamshire, 
U. K.).  LabCyte Epi-Model (a three-dimensional cultured human skin model) was obtained 
Japan Tissue Engineering Co., Ltd. (Gamagori, Aichi, Japan).  Sphingomyelin-based 
liposomes were prepared using a high pressure extrusion method by Daiichi Fine Chemical 
Co., Ltd, Takaoka, Toyama, Japan.  In briefly, sphingomyelin was dissolved in ethanol.  
Distilled water and methylparaben were added and emulsified. It was extruded through the 
membrane filters (200nm) by high pressure.  The liposomes are referred to PANASOME
®
 
SPM.   Other reagents were obtained commercially and used without further purification 
 
2-2. Characterization of liposomes 
  Particle diameter of sphingomyelin-based liposomes was measured by dynamic light 
scattering using a Zetasizer (3000HSA, Sysmex, Kobe, Japan).  Structure of these liposomes 
was analyzed by negative stain with a transmission electron microscopy (JEM 1010, Jeol, 
Tokyo, Japan). 
 
2-3. Measurement of ceramide amount in three dimensional cultured human skin model. 
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Three wells of LabCyte Epi-Model were washed by 1.0 mL of PBS and homogenized 
by 1.6 mL of 0.25 M sucrose.  Separately, 0.24 µCi/mL of [N-methyl-
14
C] Sphingomyelin 
(50 µL) was added in 20 µL of 1% Triton X-100 in acetate buffer (pH 5.0).  Then, 30 µL of 
distilled water and 50 µL of 0.2 M acetate buffer (pH 5.0) were added and sonicated for 10 
min.  Then, diluted [N-methyl-
14
C] sphingomyelin solution (50 µL) was added to 1.0 mL of 
the homogenized solution of cultured human skin samples.  The sample (0.2 mL) was 
incubated at 37°C for 1, 2 and 3 hours.  Chloroform: methanol (2: 1 v/v) (0.8 mL) was added 
to stop the reaction of sphingomyelin to phosphocholine and ceramides.  The produced free 
[
14
C]-phosphocholine was measured by a liquid scintillation counter (LSC-6100, Aloka, 
Tokyo, Japan). 
 
2-4. Application of sphingomyelin-based liposomes and extraction of ceramide II from 
LabCyte Epi-Model. 
1.0% Sphingomyelin-based liposomes in physiological saline or the saline alone 
(control) (1.0 mL each) were applied on the basal layer side or stratum corneum side of 
LabCyte Epi-Model for 24 hours.  Sphingomyelin powder in physiological saline was also 
applied for comparison.  Medium containing ascorbic acid was exchanged for enhancing 
keratinization.  After 24 hours, ceramides in the cultured skin model were extracted by 6.0 
mL of chloroform:methanol (2:1 v/v).  
 
2-5. Lipid analysis by HPTLC (high performance thin-layer chromatography) 
The extracted ceramides were separated by an HPTLC plate (Silica Gel 60, Merck, 
Darmstadt, Germany).  The HPTLC was developed twice with chloroform:methanol:acetic 
acid = 190:9:1 (v/v).  Ceramides were visualized by treatment with 10 % CuSO4, 8 % H3PO4 
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aqueous solution and heating to 180 °C for 10 min.  Ceramide II on the HPTLC plate was 
quantitatively determined by a densitometer.   
 
2-6. Statistic analysis 
The obtained data were represented as the mean ± S.D. of four experiments.  The 
statistical test was done using Welch’s t-test. 
  
3. Results 
3-1. Characterization of sphingomyelin-based liposomes 
Sphingomyelin-based liposomes prepared by a high pressure emulsification method 
have no entrapped drugs or active ingredients for drug or cosmetic formulations.  The 
liposomes were very stable even at 40 degree Celsius for 6 months.  Particle size and zeta 
potential of sphingomyelin-based liposomes were measured by a dynamic laser scattering and 
an electrophoresis, respectively.  The observed particle diameter was 155.3 ± 0.46 nm and 
zeta potential was and -11.4 mV.  Figure 2 shows a transmission electron microphotograph 
of sphingomyelin-based liposome (Fig. 2a), suggesting that the sphingomyelin liposomes had 
a core shell and lamella structure, as like in general liposomes prepared by 
phosphatidylcholine and cholesterol (Fig 2b). 
 
Figure 2a and 2b 
 
3-2. Increase in ceramide II level in LabCyte Epi-Model 
Figure 3 shows the application effect of sphingomyelin-based liposomes on the 
increased amount of ceramide II in LabCyte Epi-Model.  [
14
C]sphingomyelin was applied 
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to LabCyte Epi-Model, and the amount of the [
14
C] phosphocholine was measured as an 
index of generation of ceramide II.  Sphingomyelinase activity was measured as the amount 
at 1, 2 and 3 hours after application of sphingomyelin-based liposomes.  The amount of 
ceramide II was 2.1, 3.9 and 7.8 nmol/well, respectively.  The amount of ceramide II in the 
LabCyte Epi-Model was linearly increased to 3 hours. 
 
Figure 3 
 
3-3. Change of ceramide II amount in LabCyte Epi-Model after application of 
sphingomyelin-based liposomes on the basal layer side of the cultured skin model. 
Sphingomyelin-based liposomes were applied to the basal layer side of epidermis of 
LabCyte Epi-Model for 6 hours.  The skin model was cultured in an enhancing keratinized 
medium containing ascorbic acid for 12 or 24 hours.  Ceramide II was separated from the 
cultured skin model and determined by an HPTLC.  Figure 4a (12 h cultivation) and b (24 h 
cultivation) show the amount of ceramide II in the cultured skin model.  The ceramide II 
amount in the skin model was significantly increased after application of 
sphingomyelin-based liposomes, being about 1.82 and 2.04 -fold higher for 12 and 24 hour 
cultivation, respectively, than that without liposome-application. 
 
Figure 4a and b 
 
3-4. Change in ceramide II amount in LabCyte Epi-Model after application of 
sphingomyelin-based liposomes on the SC side. 
Next, sphingomyelin-based liposomes were applied to the SC side for 24 or 48 hours.  
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The same cultivation was done as above.  Ceramide II was separated from the cultured skin 
model and determined by an HPTLC.  Figure 5a (24 hr application) and b (48 hr application) 
show the amount of ceramide II in the skin model.  The ceramide II level was also 
significantly increased after application of the liposomes on the SC side, being about 0.90 and 
1.24-fold higher with 24 and 48 hour cultivation, respectively, than that without liposome 
application. 
 
Figure 5a and b 
 
4. Discussion 
Liposomes were prepared using sphingomyelin mostly and applied on the basal layer 
or SC side of a three-dimensional cultured human skin model, LabCyte Epi-Model, to 
investigate change in the ceramide II level in the cultured skin model.   Chemical structure 
of the ceramides was identified as seven kinds by constitution of free fatty acids and 
hydroxyl-groups.  In the present manuscript, production of type II ceramide was focused, 
because this type of ceramide is mostly effective against the skin moisturization in human 
face and body.  The sphingomyelin-based liposomes prepared by a high pressure 
emulsification were characterized: particle diameter and zeta potential of the liposomes were 
155.3 nm and -11.4 mV, respectively, and they have lamella and spherical structure, which 
was also evaluated by transmission electron microscopy (Fig. 2).  The sphingomyelin-based 
liposomes were applied to LabCyte Epi-Model to examine the sphingomyelinase activity or 
ceramide level.  This is the first report showing the sphingomyelinase activity in the 
three-dimensional cultured human skin model.  The ceramide II amount was linearly 
increased for 3 hours after application of sphingomyelin-based liposomes (Fig. 3).  These 
  10 
results suggest that the cultured skin model has sphingomyelinase activity.  When 
sphingomyelin-based liposomes were applied to LabCyte Epi-Model, ceramide II level was 
started to increase compared to that without the liposome application (Figs. 4 and 5).  
Ceramides were generated from sphingomyelin as a formulation of liposomes in LabCyte 
Epi-Model.  Real human skin also has sphingomyelinase activity.  Change in ceramide II 
amount in LabCyte Epi-Model after application of sphingomyelin powder in physiological 
saline as well as the sphingomyelin-based liposomes on the SC and basal layer side (data not 
shown).  Ceramide II amount in the skin model by the SC-side application was similar to 
that by basal layer-side application.  However, sphingomyelin-based liposomes have a great 
advantage compared with sphingomyelin powder in saline from view points formulation 
stability and easy to preparation. 
Thus, the present sphingomyelin-based liposomes must be effective to enrich the 
ceramide level in human skin.  In addition, liposome formulation is very useful to apply 
sphingomyelin on skin, since the lipid itself is difficult to formulate in conventional 
formulations.  Type II and V ceramides are reported to be produced from sphingomyelin in 
the viable epidermis by sphingomyelinase (Jensen, 2004).  In a future study, it is necessary 
to investigate the change in the amount of other ceramides except type II ceramide.  
 
Conclusion 
Sphingomyelin-based liposomes were applied on the basal layer or SC of 
three-dimensional cultured human skin model, and the ceramide II level was increased by the 
liposomes.  These results suggest that the sphingomyelin-based liposomes may have a 
moisturizing effect and barrier-keeping function in SC. 
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Figure Captions 
 
Fig. 1 Metabolic pathway of ceramides in epidermis 
Fig. 2  TEM image of sphingomyelin-based liposome (a) and phosphatidylcholine / 
cholesterol = 7/3 (m/m%) liposomes (b) 
Fig. 3  Increase in ceramide II amount in LabCyte Epi-Model 
Fig. 4 Change of ceramide II amount in LabCyte Epi-Model after application of 
sphingomyelin-based liposomes on the basal layer side of the cultured skin model. 
Sphingomyelin liposomes were applied to the basal layer side of epidermis for 6 
hours. After the skin model was cultured in an enhancing keratinized medium 
containing ascorbic acid for 12 (a) or 24 (b) hours. The data represent the average 
and standard deviation (n=4).  * and ** : p < 0.05 and p < 0.01, respectively, 
compared to the control group. SPM-L: sphingomyelin-based liposomes. 
Fig. 5 Change in ceramide II amount in LabCyte Epi-Model after application of 
sphingomyelin-based liposomes on the stratum corneum side of the cultured skin 
model.  Sphingomyelin liposomes were applied to the stratum corneum side for 24 
(a) or 48 (b) hours, after the skin model was cultured in an enhancing keratinized 
medium containing ascorbic acid for 24 hours.  The data represent the average and 
standard deviation (n=4).  ** : p < 0.01, N.S.: not significant, respectively, 
compared to the control group.  SPM-L: the same as in Fig. 4. 
 
 
 
